PharmaTimes March edition ponders, wrestles and wonders at the present life sciences zeitgeist – what a time to be alive! As the cover boldly suggests, we are in an era of patient autonomy and, thus, a brave new landscape in which the population expect and deserve access to medicines. Features examine shifting politics, the rise of "super employees," and ongoing innovation. Articles cover GLP-1s, difficult-to-treat cancers, top therapies of 2026, and AI's relentless advance.



























